Neo-DAB: Darolutamide and Abemaciclib in Prostate Cancer

Clinical trial NCT05617885 · COMPLETED

Trial details

NCT number: NCT05617885
Sponsor: Praful Ravi, MB BCHir, MRCP
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Metastatic Prostate Cancer Non-metastatic Prostate Cancer Prostate Cancer

Start date: 2023-08-09
Primary completion: 2025-07-15
Enrollment: 9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.